Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,150

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Chronic Hepatitis
Interventions
DRUG

Peginterferon alpha-2a + Ribavirin

"Administration of ribavirin at a dosage of 1000 or 1200 mg per day based on body weight \< or \> 75 kg for 24 weeks (Arm A).~Treatment duration of 48 weeks with standard fixed dose of ribavirin (800 mg/day) (Arm B).~These schedules will be compared with diagram of standard therapy with 800 mg daily of ribavirin for 24 weeks (Arm C)"

Trial Locations (35)

71013

"IRCCS Casa Sollievo della Sofferenza", San Giovanni Rotondo

Unknown

Infectious Diseases Unit, Avellino

"Clinical Medicine Unit Mater Dei", Bari

Università di Bari, Bari

Medicine Unit, Barletta

"Infectious Diseases Unit V. Emanuele", Bisceglie

Medicine Unit, Canosa di Puglia

Hepatology Unit, Casarano

"IRCCS De Bellis", Castellana Grotte

Hepatology Unit, Catania

Infectious Diseases Unit, Catania

Gastroenterology Unit, Como

"Gastroenterology Unit Arcispedale S. Anna", Ferrara

Gastroenterology Unit, Florence

Internal Medicine University of Firenze, Florence

Gastroenterology Unit, Foggia

Infectious Diseases, Foggia

Gastroenterology Unit, Galatina

Infectious Diseases, Lucca

Gastroenterology Unit, Mottola

"Gastroenterology Unit Cardarelli", Napoli

USL Napoli 1, Napoli

"Hospital V. Cervello", Palermo

Medical Clinic University of Palermo, Palermo

"Infectious Diseases Unit IRCCS San Matteo", Pavia

Campus Biomedico University, Roma

"Hepatology Unit S. Pertini", Roma

"Hepatology Unit san Camillo", Roma

"Ospedale Villa Betania", Roma

"IRCCS L. Spallanzani", Rome

Infectious Diseases Unit Ospedale Civile, Sassari

Medicine Unit, Sassari

Infectious Diseases, Syracuse

SS. Annunziata, Taranto

Medicine Unit, Venosa

All Listed Sponsors
collaborator

Casa di Cura Mater Dei

UNKNOWN

collaborator

IRCCS L. Spallanzani

UNKNOWN

collaborator

Ospedale Francesco Ferrari

OTHER

collaborator

Azienda Ospedaliero Universitaria di Sassari

OTHER

collaborator

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

collaborator

Arcispedale S. Anna, Ferrara

UNKNOWN

collaborator

Azienda Ospedaliero-Universitaria, Catania

UNKNOWN

collaborator

Ospedale di Venosa

UNKNOWN

collaborator

Ospedale Monsignor R. Dimiccoli, Barletta

OTHER

collaborator

IRCCS De Bellis, Castellana

UNKNOWN

collaborator

USL Napoli 1

UNKNOWN

collaborator

Ospedale San Giuseppe Moscati, Avellino

UNKNOWN

collaborator

Cardarelli Hospital

OTHER

collaborator

Ospedale Civile Vittorio Emanuele II, Bisceglie

UNKNOWN

collaborator

Azienda Ospedaliero-Universitaria Careggi

OTHER

collaborator

Azienda Ospedaliera V. Cervello

OTHER

collaborator

Ospedale Civile Spirito Santo

OTHER

collaborator

Ospedale di Canosa di Puglia

UNKNOWN

collaborator

University of Palermo

OTHER

collaborator

San Camillo Hospital, Rome

OTHER

collaborator

Campus Bio-Medico University

OTHER

collaborator

Ospedale Sandro Pertini, Roma

OTHER

collaborator

Ospedali Riuniti di Foggia

OTHER

collaborator

Ospedale SS. Annunziata, Taranto

UNKNOWN

collaborator

Ospedale di Mottola

UNKNOWN

collaborator

Ospedale Santa Caterina Novella, Galatina

UNKNOWN

collaborator

University of Florence

OTHER

collaborator

Ospedale Valduce, Como

UNKNOWN

collaborator

University of Bari

OTHER

collaborator

Azienda Ospedaliera, Siracusa

UNKNOWN

collaborator

Azienda Ospedaliera, Lucca

UNKNOWN

lead

Casa Sollievo della Sofferenza IRCCS

OTHER

NCT01380938 - Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE) | Biotech Hunter | Biotech Hunter